Home/MetaCurUm Biotech/Maréne Landström
ML

Maréne Landström

Founder, Chief Scientific Officer

MetaCurUm Biotech

Therapeutic Areas

MetaCurUm Biotech Pipeline

DrugIndicationPhase
Monoclonal Antibody (undisclosed)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Preclinical